Menopause, a universal female experience: Lessons from Mexico and Central America

Current Women's Health Reviews

Volumn 4, Issue 1, 2008, Pages 3-8

  Locklear, Tracie D ^a   Doyle, Brian J ^a   Huang, Yue ^b   Perez, Alice L ^c   Caceres, Amando ^d   Mahady, Gail B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c UNIVERSIDAD DE SAN CARLOS DE GUATEMALA   (Guatemala)

^d NONE

Author keywords

Attitudes; Costa Rica; Ethnicity; Guatemala; Maya women; Menopause; Mexico; Osteoporosis; Treatment; Vasomotor symptoms

Indexed keywords

ANGELICA SINENSIS EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; PRIMROSE OIL; RED CLOVER EXTRACT; SOYBEAN OIL; VITAMIN;

ANXIETY; CANCER RISK; CARDIOVASCULAR RISK; CENTRAL AMERICA; COGNITION; CULTURAL FACTOR; DIET SUPPLEMENTATION; DRUG SAFETY; ENVIRONMENTAL FACTOR; EXERCISE; HORMONE SUBSTITUTION; HUMAN; HYDROTHERAPY; LACTATION; MASSAGE; MATERNAL ATTITUDE; MATERNAL NUTRITION; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUATION; MEXICO; POSTMENOPAUSE OSTEOPOROSIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; STIGMA; UNITED STATES; WORKLOAD;

EID: 47749136682     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340408783572033     Document Type: Review

References (69)

1. Anon. WHO Annual Report 2001, WHO Publications Office, Geneva, Switzerland, 2003.
2. World Health Report 1999. Making a difference. http://www.who.int/whr/ 1999. Accessed December 3, 2006.
3. Hill K. The demography of menopause. Maturitas 1996; 23: 113-27.
4. Houmard BS, Seifer DB. In: Seifer DB, Kennard EA, Eds, Menopause, Endocrinology and Management. Totowa, NJ. Humana Press, 1999; 1-20.
5. Mahady GB. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 2005; 4:177-84.
6. Mahady GB, Doyle BJ, Locklear TD, Cotler S, Hartman G. Krishnaraj R. Black cohosh (Actaea racemosa) for the mitigation of menopausal symptoms: recent developments in clinical safety and efficacy. Women's Health 2006; 2: 773-83.
7. World Health Organization Scientific Group. Research on the menopause. WHO Technical Report Ser. 670, World Health Organization, Geneva Switzerland, 1981.
8. Rice VM. Strategies and issues of managing menopause-related symptoms in diverse populations: ethnic and racial diversity. Am J Med 2005; 118(12B): 142S-7S.
9. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87: 897-904.
10. Gorodeski, G. Update on cardiovascular disease in postmenopausal women. Best Practice and Research Clinical Obstetrics and Gynecology 2002; 16(3): 329-55.
11. Yoon B, Kim DK, Kang, Y, Kim J, Shin M, Na DL. Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study. Fertility and Sterility 2003; 79(2): 274-80.
12. Bradley JV. Genitourinary symptoms in the menopausal transition. Am J Med 2001; 118(12b): 47S-53S.
13. Palacios S, Sanchez-Borregp R, Forteza A. The importance of preventative health care in post-menopausal women. Maturitus, 2006; 52: S53-S60.
14. National Osteoporosis Foundation. Disease Facts. http://www.nof.org/ osteoporosis/diseasefacts.htm. Accessed November 07, 2006.
15. Beyene Y. Cultural significance and physiological manifestations of menopause: a biocultural analysis. Cult Med Psychiatry 1986; 10: 47-71.
16. Stewart DE. Menopause in Highland Guatemala Mayan women. Maturitas 2002; 43(1): 11-19.
17. Michel JL, Mahady GB, Valiz M, Sojarto DD, Càceres A. Symptoms, attitudes and treatment choices surrounding menopause among the Q'eqchi Maya of Livingston, Guatemala. Soc. Sci Med 2006; 63(3): 732-42.
18. Lock M, Kaufert P. Menopause, local biologies, and cultures of aging. Am J Hum Biol 2001; 13: 494-504.
19. Mishra G, Kuh D. Perceived change in quality of life during menopause. Soc Sci Med 2006; 62: 93-102.
20. Brosage P. Hormone therapy: The woman's decision. Contemp Nurse Pract 1995; S1: 3.
21. Feldman BM, Voda A, Gronseth E. The prevalence of hot flash and associated variables among peri-menopausal women. Res Nurs Health 1985; 8(3): 261-68.
22. Fitzpatrick LA. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin Proc 1999; 74(6): 601-607.
23. Freedman RR. Physiology of hot flashes. Am J Hum Biol 2001; 13: 453-64.
24. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of Demographic and lifestyle factors to symptoms in a multi-racial/ethic population of women 40-55 years of age. Am J Epidemol 2000 152(5): 463-73.
25. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol 1992; 4: 37-46.
26. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomology. Women's Health 1997; 3: 103-20.
27. Schwingl PJ, Hulka BA, Harlow SD. Risk factors of menopausal hot flashes. Obstet Gynecol 1994; 84(1): 29-34.
28. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000; 35(1): 3-9.
29. Ortega-Ceballos PA, Moran, C, Blanco-Munoz, J, Yunes-Diaz, E, Castaneda-Iniguez, MS, Salmeron J. Reproductive and lifestyle factors associated with early menopause in Mexican women. Salud publica de Mexico 2006; 48(4): 300-307.
30. Avis NE, Ory M, Matthews KA, Schoken M, Bromberger J, Colvin A. Health-related quality of life in a multiethnic sample of middle aged women: Study of women's health across the nation (SWAN). Med Care 2003; 41: 1262-76.
31. Aiello EJ, Yasui Y, Tworoger SS, et al. Effect of a year-long, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause 2004; 11(4): 372-74.
32. Randolph JF Jr., Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004; 89(4): 1555-61.
33. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001; 52: 345-56.
34. Grodstein F, Stampler MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. New Eng J Med 1997; 336:1769-75.
35. Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 200l; 185: S13-23.
36. Rossou JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
37. Adams C, Cannell S. Women's beliefs about "natural" hormones and natural hormone replacement therapy. Menopause 2001; 6: 433-40.
38. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: A review of randomized; controlled trials. Ann Intern Med 2002; 137(10): 805-13.
39. Low Dog T, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptoms relief. Menopause, 2003; 10(4): 299-13.
40. Longworth, JC. Hispanic women's experience with "el cambio de vida". J Am Acad Nurse Pract 2003; 15(6): 266-75.
41. Gavaler, JS. Oral hormone replacement therapy: Factors that influence the estradiol concentrations in a multiracial study population. J Clin Pharmacol 2002; 42: 137-44.
42. Laws M, Carballeira N. Use of nonallopathic healing methods by Latina women at midlife. American J Pub Health 2003; 93(4): 524.
43. Mahady GB, Parrot J, Lee C, Yun GS, Dan A. O. Botanical dietary supplement use in pre- and postmenopausal women. Menopause 2003; 10(1): 65-72.
44. Bell ML. Attitudes toward menopause among Mexican American women. Health Care Women Int 1995; 16: 425-35.
45. Kay M, Voda A, Olivas G, Rios F, Imle M. Ethnography of the menopause-related hot flash. Maturitas 1982; 4(3): 217-27.
46. Blümel JE, Chedraui P, Calle A, et al. Age at menopause in Latin America. Menopause: J North Am Menopause Soc 2006; 13(4): 706-712.
47. Malacara JM, Canto de Cetina T, Bassol S, et al. Symptoms at pre-and postmenopause in rural and urban women from three States of Mexico. Maturitas 2002; 43(1): 11-19.
48. Stewart DE. Menopause in highland Guatemala Mayan women. Maturitas 2003; 44: 293-97.
49. Beyene Y, Martin MC. Menopausal experiences and bone density of Mayan women in Yucatan. Am J Hum Biol 2001; 13(4): 505-11.
50. Beyene Y. From menarche to menopause: reproductive lives of peasant women in two cultures. Albany: State University of New York Press. 1989.
51. Vermeulen A. Environment, human reproduction, menopause, and andropause. Environ Health Perspect 1993; 101 Suppl 2: 91-100.
52. Martin MC, Block JE, Sanchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993; 168: 1830-46.
53. Cant-de-Cetina TE, Canto-Cetina P, Polanco-Reyes L. Survey of climacteric symptoms in semi-rural areas of Yucatan. Rev Inves Clin 1998; 50: 133-35.
54. Sievert LL, Freedman RF, Garcia JZ, et al. Measurement of hot flashes by external skin conductance and subjective hot flash report in Puebla, Mexico. Menopause 2002; 9: 367-76.
55. Sievert LL, Espinosa-Hernandez G. Attitudes towards menopause in relation to symptom experience in Puebla, Mexico. Women's Health 2003; 38(2): 93-106.
56. Giron L, Freire V, Alonzo A, Caceres A. Ethnobotanical survey of the medicinal flora used by the Caribs of Guatemala. J Ethnopharmacol 1991; 34(2-3): 173-87.
57. Pan American Health Organization (PAHO). Traditional Health Systems in Latin America and the Caribbean: Base Information Technical Project Report, 1999.
58. Bixby LR. Assessing the impact of health sector reform in Costa Rica through a quasi-experimental study. Rev Panam Salud Publica 2004; 15: 94-103
59. Rosero-Bixby L. Spatial access to health care in Costa Rica and its equity: a GIS-based study. Soc Sci Med 2004; 58(7): 1271-84.
60. Monge-Rojas R, Nunez HP. Dietary calcium intake by a group of 13-18 year old Costa Rican teenagers. Arch Latinoam Nutr 2001; 51(2): 127-31.
61. Gris Martinez JM. Isoflavones in menopause women. Med Clin (Barc) 2006; 127(9): 352-56.
62. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87: 897-904.
63. Knight DC, Lyons Wall P, Eden JA. A review of phytoestrogens and their effects in relation to menopausal symptoms. Aust J Nutri Diet 1996; 53: 5-11.
64. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum hpids. N Engl J Med 1995; 333 (5): 276-82.
65. Kabagambe EK, Baylin A, Ruiz-Narvarez E, Siles X, Campos H. Decreased consumption of dried mature beans is positively associated with urbanization and not fatal acute myocardial infarction. J Nutr 2005; 135(7): 1770-75.
66. Valente M, Bufalino L, Castiglione GN, et al. Effects of 1-year treatment with ipriflavone on bone in premenopausal women with low bone mass. Calcif Tissue Int 1994; 54: 377-80.
67. Murkies AL, Wilcox G, Davis SR. Phytoestrogens. J Clin Endocrinol Metab 1998; 83: 297-303.
68. Sommer B, Avis N, Meyer P, et al. Attitudes toward menopause and aging across ethnic/racial groups. Psychosom Med 1999; 61: 868-875.
69. Palacios S, Borrego RS, Forteza A. The importance of preventive health care in post-menopausal women. Maturitas 2005;52 Suppl 1:S53-60.